Futura Medical plc (FAMDF)

Market Cap	36.64M
Revenue (ttm)	17.43M
Net Income (ttm)	1.62M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	22.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,623
Average Volume	1,190
Open	0.1300
Previous Close	0.1110
Day's Range	0.1300 - 0.1300
52-Week Range	0.0100 - 0.6000
Beta	0.83
RSI	57.70
Earnings Date	Jun 10, 2025

About Futura Medical

Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 14
• Stock Exchange: OTCMKTS
• Ticker Symbol: FAMDF

Financial Performance

Financial numbers in GBP